Clinical Trials Logo
  1. Home
  2. Healthy Participant
  3. NCT05311865

Transmission of Covid-19 During Clubbing Events in Closed Places — ITOC  

Healthy Participant Clinical Trial

Official title:
Transmission of Covid-19 During Clubbing Events in Closed Places

Clinical Trial Summary

The ITOC study is a cluster randomised, controlled, multicentre trial in Paris region, France. The intervention is an 8-hour indoor clubbing event with no mask wearing, no social distancing, at maximum room capacity. 1,200 healthy volunteers aged 18-49 years and fully vaccinated will be included. Participants are recruited by group of up to 10, to be randomized 2:1 to experimental group (800 volunteers in a venue ) or control group (400 volunteers asked to stay at home). All participants will provide a salivary sample the day of experiment and seven days later. Participants will also answer surveys on the social and psychological impact of lockdown and indoor club closing, attitude towards vaccination, behaviour at risk of COVID-19 transmission during the day of the event (for both groups) as well as follow-up surveys on symptoms that participant may experience. Virological analyses include polymerase chain reaction (PCR) of salivary samples and air of the venue, investigating SARS-CoV-2 PCR.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05311865
Study type Interventional
Source ANRS, Emerging Infectious Diseases
Contact
Status Completed
Phase N/A
Start date September 4, 2021
Completion date February 26, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05520216 - Effect of Rib Cage and Spine Mobility on Maximum Breath-Hold Time
Active, not recruiting NCT04807465 - Different Modes of Universal Adhesive in Smokers and Non-Smokers N/A
Completed NCT06087055 - Drug-Drug Interaction Study of Itraconazole With GST-HG171/Ritonavir in Healthy Participants Phase 1
Completed NCT04962022 - Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants Phase 1
Completed NCT04962230 - Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir Phase 1
Completed NCT05450549 - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL919 in Healthy Participants Phase 1
Active, not recruiting NCT04814836 - Laser Etching Effect on Application Mode of Universal Adhesive N/A